Bioblue Technology focuses on the research and development of early tumor diagnosis products such as serum autoantibody profiles of lung cancer. Bioblue Technology's first key product project for early-stage lung cancer non-invasive screening independently adopts the world's leading liquid-phase chip technology, which has important